as of 12-05-2025 4:00pm EST
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | HORSHAM |
| Market Cap: | 8.9M | IPO Year: | 2005 |
| Target Price: | $6.00 | AVG Volume (30 days): | 83.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.24 - $3.86 | Next Earning Date: | 11-13-2025 |
| Revenue: | $30,980,000 | Revenue Growth: | -5.19% |
| Revenue Growth (this year): | -9.14% | Revenue Growth (next year): | 7.74% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$1.40
Shares
5,000
Total Value
$7,028.32
Owned After
5,934
Director
Avg Cost/Share
$1.34
Shares
14,094
Total Value
$18,803.84
Owned After
12,360
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Rubinstein Samuel | SSKN | Director | Nov 18, 2025 | Buy | $1.40 | 5,000 | $7,028.32 | 5,934 | |
| Rubinstein Samuel | SSKN | Director | Nov 17, 2025 | Sell | $1.34 | 14,094 | $18,803.84 | 12,360 |
See how SSKN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SSKN Strata Skin Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.